FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to novel derivatives of spiropiperidine of the general formula (I) where R1 means phenyl group that can be optionally substituted with 1-3 substituents taken among halogen atoms, lower alkyl groups, halogen-lower alkyl groups, lower alkoxy-groups, lower alkoxycarbonyl group, hydroxyl groups, lower aliphatic acylamino-groups, cyano-groups or 5- or 6-membered heterocyclic group comprising 1-3 oxygen, sulfur and/or nitrogen atoms that can be optionally condensed with phenyl group; R2 means phenyl group that is substituted with 1-3 fluorine or chlorine atoms; A means carbonyl group; B means an ordinary bond; D means oxygen or sulfur atom; E means C1-4-alkylene group; means the group of the formula (II) where G means C5-8-alkane ring substituted with hydroxyl group; Ar means phenyl ring; n is a whole number 1 or 2; or their pharmacologically acceptable alts. Invention relates to also a medicinal agent showing an antagonistic effect with respect to NK1-, NK2- and NK3-receptors and containing compound of the formula (I) or its pharmacologically acceptable salt as an effective component and excipient. Proposed compounds can be used for treatment or prophylaxis of disease that can be treated or prevented with agents showing an antagonistic effect with respect to NK1-, NK2- and NK3-receptors by administration of compound of the formula (I) or its pharmacologically acceptable salt in warm-blooded animal in effective dose. EFFECT: new derivatives of spiropiperidine indicated above, valuable pharmacological properties. 12 cl, 3 tbl
Title |
Year |
Author |
Number |
ACYLATED HETEROALICYCLIC DERIVATIVES, MEDICINAL AGENT SHOWING SELECTIVE ANTAGONISTIC ACTIVITY AGAINST NK-RECEPTORS, METHOD OF PROPHYLAXIS OR TREATMENT OF PATIENTS |
1998 |
- Nisi Takakhide
- Jamaguti Takesi
|
RU2174122C1 |
INDANOL DERIVATIVES |
2005 |
- Nisi Takakhide
- Takemoto Tosijasu
- Ikeda Takuja
- Morimoto Kijosi
|
RU2323937C1 |
COMPOUND SALTS, MEDICINAL AGENT, COMPOSITION, METHOD OF PROPHYLAXIS, METHOD OF TREATMENT |
1998 |
- Nisi Takakhide
- Jamaguti Takesi
|
RU2190615C2 |
HETEROCYCLIC COMPOUNDS AND COMPOSITION ON SAID SHOWING ANTAGONISTIC EFFECT WITH RESPECT TO TACHYKININ RECEPTORS |
1996 |
- Takakhide Nisi
- Koki Isibasi
- Katsujosi Nakadzima
- Tetsuja Fukazava
- Khitosi Kurata
- Takesi Jamaguti
- Kazukhiro Ito
|
RU2135494C1 |
DERIVATIVES OF TRIAZOLE OF AMIDE TYPE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR PROPHYLAXIS OR TREATMENT |
2001 |
- Utida Takuja
- Konosu Tosijuki
|
RU2232761C2 |
α, ω-DIARYL ALKANES AND METHOD FOR THEIR PRODUCTION |
1993 |
- Kojti Fudzimoto[Jp]
- Naoki Tanaka[Jp]
- Fumitosi Asaj[Jp]
- Tomijosi Ito[Jp]
- Khirojuki Kojke[Jp]
|
RU2105752C1 |
DERIVATIVES OF AMINOALCOHOLS, PHARMACEUTICAL COMPOSITION, METHOD FOR PROPHYLAXIS OR TREATMENT, INTERMEDIATE COMPOUNDS AND METHOD FOR PREPARING INTERMEDIATE COMPOUNDS |
2001 |
- Nisi Takakhide
- Takemoto Tosijasu
- Simozato Takaiti
- Nara Futosi
|
RU2233839C1 |
DERIVATIVES OF DIARYLALKANES CONTAINING ALICYCLIC GROUP AND ELICITING ANTAGONISM WITH RESPECT TO SEROTONIN-2-RECEPTORS AND/OR INHIBITORY ACTIVITY WITH RESPECT TO SQUALENE SYNTHASE, COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF CARDIOVASCULAR DISEASES |
1997 |
- Koiti Fudzimoto
- Naoki Tanaka
- Fumitosi Asaj
- Taketosi Ogava
- Tejitiro Koga
- Tatsuo Tanimoto
- Esio Tsudzita
- Khirojuki Kojke
|
RU2139277C1 |
FUNGICIDAL OXETANE DERIVATIVES AND SALTS THEREOF |
1992 |
- Khideo Takesiba[Jp]
- Dzunzo Tobitsuka[Jp]
- Kazuo Sato[Jp]
- Khisaki Kadzino[Jp]
- Khirojuki Itokh[Jp]
- Jukiesi Takakhi[Jp]
- Khirosi Okhta[Jp]
- Sadao Onda[Jp]
- Noriko Takeda[Jp]
- Tosijuki Konosu[Jp]
- Khirosi Jasuda[Jp]
|
RU2044736C1 |
NEW NUCLEOSIDE AND OLIGONUCLEOTIDE ANALOGUES |
2000 |
- Kaneko Masakatsu
- Morita Kodzi
- Imanisi Takesi
|
RU2233844C2 |